Order the British Pharmacopoeia 2024
The British Pharmacopoeia (BP) 2024 edition from the Medicines and Healthcare products Regulatory Agency (MHRA) is available to order in hard copy and online formats helping you to access quality and compliance, quickly, easily and with confidence.
The BP is essential in ensuring you comply with official standards for UK pharmaceutical substances and medicinal products.
Included with your purchase is access to all European Pharmacopoeia texts. The 2024 edition also includes:
Monographs and BPCRS:
- 27 new BP monographs, 17 new Ph. Eur. monographs.
- 93 amended BP monographs.
- all monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.1 and 11.2.
- Ph. Eur. supplements 11.3 to 11.5 included as in-year online and download product updates.
- updated references to new BPCRS included in the BP 2024 to ensure that you remain compliant.
Online tools and guides:
We will be updating pharmacopoeia.com to improve your experience of using our site. A new beta will be available soon, with new features including:
- find what you need more easily with a new and improved site design and navigation.
- self-serve online with Improved purchase journeys.
- an updated timeline and tracked changes to better visualise changes to monographs
Additional supporting content:
Analytical Quality by Design (AQbD) guidance provides the principles to develop additional method understanding and a greater assurance of the analytical procedures used to uphold product quality throughout the product’s lifecycle.
The Advanced Therapy Medicinal Products (ATMP) Flow Cytometry and Vector Copy Number best practice guidance texts offer a practical and phase appropriate validation tool to help your cell therapy programme succeed.